CAI — Price & Float Short

—— Fair value ★ EPS beat ★ EPS miss —— Target Price

Float Short %

10.41

Margin Of Safety %

Put/Call OI Ratio

0.99

EPS Next Q Diff

EPS Last/This Y

3.37

EPS This/Next Y

0.23

Price

15.56

Target Price

Analyst Recom

1.38

Performance Q

-11.85

Upside

-430.9%

Beta

Ticker: CAI

22 items of 1

Date	Symbol	Latest	P/C OI	P/C Vol	Total OI
2026-04-23	CAI	19.8	1.48	0.25	6010
2026-04-24	CAI	20.21	1.47	1.00	6037
2026-04-27	CAI	19.93	1.48	0.00	6050
2026-04-28	CAI	18.44	1.47	0.08	6053
2026-04-29	CAI	17.76	1.47	2.96	6067
2026-04-30	CAI	18.99	1.49	0.03	6154
2026-05-01	CAI	18.49	1.42	0.50	6269
2026-05-04	CAI	18.68	1.42	0.00	6278
2026-05-05	CAI	18.96	1.42	0.08	6290
2026-05-06	CAI	19.13	1.36	0.19	6393
2026-05-07	CAI	19.85	1.34	0.41	6434
2026-05-08	CAI	16.15	1.34	1.71	6866
2026-05-11	CAI	15.94	1.35	2.62	7236
2026-05-12	CAI	16.76	1.32	0.63	7473
2026-05-13	CAI	14.68	1.30	0.68	7576
2026-05-14	CAI	15.25	1.16	1.03	8165
2026-05-15	CAI	14.56	1.12	1.25	8178
2026-05-18	CAI	15.12	0.79	0.32	6094
2026-05-19	CAI	14.97	0.77	7.98	6435
2026-05-20	CAI	15.7	1.01	0.18	7555
2026-05-21	CAI	15.94	0.99	0.12	7599
2026-05-22	CAI	15.55	0.99	0.54	7623
Date	Symbol	Latest	P/C OI	P/C Vol	Total OI

22 items 1 of 1

22 items of 1

Date	Ticker	Price	Current Quarter Growth Estimate	EBIT Estimation	Average EPS Estimate Current Year
2026-04-23	CAI	19.80	-	78.2	0.14
2026-04-24	CAI	20.21	-	82.3	0.14
2026-04-27	CAI	19.94	-	79.8	0.14
2026-04-28	CAI	18.44	-	75.2	0.14
2026-04-29	CAI	17.76	-	78.0	0.14
2026-04-30	CAI	18.99	-	85.9	0.14
2026-05-01	CAI	18.49	-	78.8	0.14
2026-05-04	CAI	18.68	-	81.5	0.14
2026-05-05	CAI	18.95	-	81.8	0.14
2026-05-06	CAI	19.12	-	81.4	0.14
2026-05-07	CAI	19.84	-	83.4	0.14
2026-05-08	CAI	16.15	-	66.9	0.14
2026-05-11	CAI	15.94	-	81.0	0.14
2026-05-12	CAI	16.79	-	-17.2	0.14
2026-05-13	CAI	14.69	-	-30.6	0.14
2026-05-14	CAI	15.26	-	-18.3	0.14
2026-05-15	CAI	14.56	-	-25.6	0.15
2026-05-18	CAI	15.10	101.5	-19.3	0.15
2026-05-19	CAI	14.96	101.5	-22.8	0.15
2026-05-20	CAI	15.70	101.5	-18.4	0.15
2026-05-21	CAI	15.94	101.5	-21.0	0.15
2026-05-22	CAI	15.56	101.5	-23.9	0.15
Date	Ticker	Price	Current Quarter Growth Estimate	EBIT Estimation	Average EPS Estimate Current Year

22 items 1 of 1

22 items of 1

Date	Ticker	Insider Transactions	Institutional Transactions	Float Short
2026-04-23	CAI	-0.04	25.64	8.58
2026-04-24	CAI	-0.04	25.64	8.58
2026-04-27	CAI	-0.04	25.60	9.82
2026-04-28	CAI	-0.04	25.60	9.82
2026-04-29	CAI	-0.04	25.60	9.82
2026-04-30	CAI	-0.04	25.60	9.82
2026-05-01	CAI	-0.04	25.60	9.82
2026-05-04	CAI	-0.04	25.65	9.82
2026-05-05	CAI	-0.04	25.65	9.82
2026-05-06	CAI	-0.04	25.65	9.82
2026-05-07	CAI	-0.04	25.65	9.82
2026-05-08	CAI	-0.04	25.65	9.82
2026-05-11	CAI	-0.04	24.71	9.82
2026-05-12	CAI	-0.02	24.71	10.61
2026-05-13	CAI	-0.02	24.71	10.60
2026-05-14	CAI	-0.02	24.71	10.60
2026-05-15	CAI	-0.02	24.71	10.60
2026-05-18	CAI	-0.02	25.43	10.43
2026-05-19	CAI	-0.02	25.43	10.43
2026-05-20	CAI	-0.02	25.43	10.43
2026-05-21	CAI	-0.02	25.43	10.41
2026-05-22	CAI	-0.02	25.43	10.41
Date	Ticker	Insider Transactions	Institutional Transactions	Float Short

22 items 1 of 1

Last Quarter Act. EPS

Avg. EPS Est. Current Quarter

0.02

Avg. EPS Est. Next Quarter

0.05

Insider Transactions

-0.02

Institutional Transactions

25.43

Beta

Average Sales Estimate Current Quarter

238

Average Sales Estimate Next Quarter

262

Fair Value

15.63

Quality Score

Growth Score

Sentiment Score

Actual DrawDown %

63.4

Max Drawdown 5-Year %

Target Price

P/E

Forward P/E

42.09

PEG

P/S

4.84

P/B

7.41

P/Free Cash Flow

37.98

EPS

-1.47

Average EPS Est. Cur. Y

0.15

EPS Next Y. (Est.)

0.37

Target Price Estimates Raised

Target Price Estimates Lowered

Profit Margin

-45.35

Relative Volume

0.68

Return on Equity vs Sector %

-96.4

Return on Equity vs Industry %

-80.8

EPS 1 7Days Diff

EPS 1 30Days Diff

0.01

EBIT Estimation

-23.9

◆ CAI Healthcare

$15.55

📉

Swing / Pullback

Buy the dip on strong trends

N/A

WEAK

Trend

0/20

Pullback

19/25

Volume

6/15

Valuation

11/20

TP/AR

2/10

Options

4/10

RSI

40.9

Range 1M

22.4%

Sup Dist

1.2%

🚀

Momentum Growth

Ride accelerating trends

N/A

WEAK

Momentum

0/25

Growth

25/30

Estimates

1/20

Inst/Vol

5/15

Options

6/10

EPS Yr

135%

EPS NY

159.2%

💎

Long-Term Value

Quality companies, undervalued

N/A

WEAK

🟡 HOLD +7.8% upside

Quality

12/30

Valuation

4/30

Growth

17/25

Stability

5/10

LT Trend

0/5

Upside

+7.8%

Quality

MoS

Caris Life Sciences, Inc.

Sector: Healthcare

Industry: Biotechnology

Employees: 1846

Caris Life Sciences, Inc., an artificial intelligence TechBio company, provides molecular profiling services in the United States and internationally. It develops and commercializes solutions to transform healthcare using molecular information, and artificial intelligence/machine learning algorithms. The company's molecular intelligence product portfolio includes MI Profile Platform, a whole exome sequencing (WES)/ whole transcriptome sequencing (WTS) tissue-based molecular profiling solutions; Caris Assure Platform WES/WTS blood-based molecular profiling solutions; Precision Whole Genome Platform, a whole genome sequencing (WGS) blood- and tissue-based profiling solutions; and Caris Detect, a WGS-based multi-cancer early detection solution; Caris WGS MRD a WGS and digital droplet polymerase reaction-based minimal residual disease solution; and Caris ChromoSeq, a WGS and WTS based assay for therapy selection in hematological cancers. It also offers pharma research and development services comprising laboratory delivery, strategic data, and research services to biopharmaceutical customers. The company provides its precision oncology solutions to customers, such as hospitals, institutions and patients. The company was founded in 2008 and is headquartered in Irving, Texas.

CAI

Latest News

—

Caricamento notizie per CAI…

stock quote shares CAI – Caris Life Sciences Inc Stock Price stock today

news today CAI – Caris Life Sciences Inc stock forecast ,stock prediction 2023 2024 2025

marketwatch CAI – Caris Life Sciences Inc yahoo finance google finance

stock history CAI – Caris Life Sciences Inc invest stock market

stock prices CAI premarket after hours

ticker CAI fair value insiders trading

Float Short %

Margin Of Safety %

Put/Call OI Ratio

EPS Next Q Diff

EPS Last/This Y

EPS This/Next Y

Price

Target Price

Analyst Recom

Performance Q

Upside

Beta

Ticker: CAI

Last Quarter Act. EPS​

Avg. EPS Est. Current Quarter

Avg. EPS Est. Next Quarter

Insider Transactions

Institutional Transactions

Beta

Average Sales Estimate Current Quarter

Average Sales Estimate Next Quarter

Fair Value

Quality Score

Growth Score

Sentiment Score

Actual DrawDown %

Max Drawdown 5-Year %

Target Price

P/E

Forward P/E

PEG

P/S

P/B

P/Free Cash Flow

EPS

Average EPS Est. Cur. Y​

EPS Next Y. (Est.)

Target Price Estimates Raised

Target Price Estimates Lowered

Profit Margin

Relative Volume

Return on Equity vs Sector %

Return on Equity vs Industry %

EPS 1 7Days Diff

EPS 1 30Days Diff

EBIT Estimation

Latest News

Last Quarter Act. EPS

Average EPS Est. Cur. Y